Activity of KRM-1648 alone or in combination with both ethambutol and kanamycin or clarithromycin against Mycobacterium intracellulare infections in beige mice

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 2, 1996, Pages 429-432

  Yamamoto, T ^a   Amitani, R ^a   Suzuki, K ^a   Tanaka, E ^a   Murayama, T ^a   Kuze, F ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYCOBACTERIAL AGENT; CLARITHROMYCIN; ETHAMBUTOL; KANAMYCIN; RIFALAZIL; RIFAMPICIN; RIFAMYCIN DERIVATIVE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MIXTURE; DRUG POTENCY; FEMALE; LUNG INFECTION; MALE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE; MYCOBACTERIUM INTRACELLULARE AVIUM; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030053503     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.2.429     Document Type: Article

References (17)

1. Bermudez, L. E., P. Kolonoski, L. S. Young, and C. B. Inderlied. 1994 Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection. Antimicrob. Agents Chemother. 38:1844-1848
2. Fernandes, P. B., D. J. Hardy, D. McDaniel, C. W. Hanson, and R. N. Swanson. 1989. In vitro and in vivo activities of clarithromycin against Mycobacterium avium. Antimicrob. Agents Chemother. 33:1531-1534.
3. Gangadharam, P. R. J., C. K. Edwards III, P. S. Murthy, and P. F. Pratt. 1983. An acute infection model for Mycobacterium intracellulare disease using beige mice, preliminary results. Am. Rev Respir. Dis. 127:648-649.
4. Horsburgh, C. R., Jr., U. G. Mason III, D. C. Farhi, and M. D. Isema. 1985. Disseminated infection with Mycobacterium avium-intracellulare. Medicine (Baltimore) 64:36-48.
5. Horsburgh, C. R., Jr., and R. M. Selik. 1989. The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am. Rev. Respir. Dis. 139:4-7.
6. Klemens, S. P., M. S. Destefano, and M. H. Cynamon. 1992. Activity of clarithromycin against Mycobacterium avium complex infection in beige mice. Antimicrob. Agents Chemother. 36:2413-2417.
7. Kuze, F. 1984. Experimental chemotherapy in chronic Mycobacterium avium-intracellulare infection of mice. Am. Rev Respir. Dis 129:453-459.
8. Kuze, F., T. Kurasawa, K. Bando, Y. Lee, and N. Maekawa. 1981. In vitro and in vivo susceptibility of atypical mycobacteria to various drugs. Rev. Infect. Dis. 3:885-897.
9. Kuze, F., T. Yamamoto, R. Amitani, and K. Suzuki. 1990. In vivo activities of new rifamycin derivatives against mycobacteria. Kekkaku 66:7-12.
10. Naik, S., and R. Ruck. 1989. In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex Antimicrob. Agents Chemother. 33:1614-1616.
11. Saito, H., and K. Sato. 1989. Activity of rifabutin and in combination with clofazimine, kanamycin and ethambutol against Mycobacterium intracellulare infection in mice. Tubercle 70:201-205.
12. Saito, H., H. Tomioka, K. Sato, M. Emori, T. Yamane, K. Yamashita, K. Hosoe, and T. Hidaka. 1991. In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycins. Antimicrob Agents Chemother. 35:542-547.
13. Saito, H., H. Tomioka, K. Sato, S. Kawahara, T. Hidaka, and S. Dekio. 1995. Therapeutic effect of KRM-1648 with various antimicrobials against Mycobacterium avium complex infection in mice Tubercle Lung Dis. 76:51-58.
14. Tomioka, H., H. Saito, K. Fujii, K. Sato, and T. Hidaka. 1993. In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method Antimicrob. Agents Chemother. 37:67-70
15. Tomioka, H., H. Saito, K. Sato, T. Yamane, K. Yamashita, K. Hosoe, K. Fujii, and T. Hidaka. 1992. Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin. KRM-1648, against Mycobacterium avium complex infection induced in mice. Antimicrob. Agents Chemother. 36:387-393.
16. Yamamoto, T., R. Amitani, F. Kuze, and K. Suzuki. 1990. In vitro activities of new rifamycin derivatives against Mycobacterium tuberculosis and M. avium complex. Kekkaku 65:805-810. (In Japanese)
17. Young, L. S. 1988. AIDS commentary. Mycobacterium avium complex infection J. Infect. Dis. 157:863-867.